Abiopharma

Maravai LifeSciences Reports Second Quarter 2025 Financial Results

Crinetics Pharmaceuticals Announces August 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Capricor Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

New Form 144 - IDEXX LABORATORIES INC /DE Filed: 2025-08-11 AccNo: 0001950047-25-005590 Size: 6 KB

New Form 8-K - Denali Therapeutics Inc. Filed: 2025-08-11 AccNo: 0001714899-25-000167 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - BIOMARIN PHARMACEUTICAL INC Filed: 2025-08-11 AccNo: 0001048477-25-000098 Size: 138 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

New Form 8-K - Azitra, Inc. Filed: 2025-08-11 AccNo: 0001701478-25-000041 Size: 257 KB Item 2.02: Results of Operations and Financial Condition

New Form 4 - Doximity, Inc. Filed: 2025-08-11 AccNo: 0001516513-25-000095 Size: 13 KB

New Form 4/A - ESTABLISHMENT LABS HOLDINGS INC. Filed: 2025-08-11 AccNo: 0001839059-25-000010 Size: 4 KB

Omeros Corporation to Announce Second Quarter Financial Results on August 14, 2025

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2025

Denali Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights

Gevo Reports Second Quarter 2025 Financial Results

TELA Bio Reports Second Quarter 2025 Financial Results

New Form 8-K - Arcturus Therapeutics Holdings Inc. Filed: 2025-08-11 AccNo: 0001193805-25-001175 Size: 275 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits